$407.29
-1.2%Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Chief Digital Officer
Compensation
$1,110,097
Chief Executive Officer & Director
Compensation
$2,637,244
Chief Executive Officer & Director
Compensation
$1,793,167
Chief Financial Officer, Head of Business Technology & Enterprise Technology Leader
Compensation
$1,049,570
Chief Information Officer
Chief Legal & Compliance Officer
Executive Chair
Compensation
$2,637,244
Executive Vice President & Chief Digital Officer
Compensation
$1,110,097
Executive Vice President and Chief Commercial & Marketing Officer
Compensation
$1,082,565
Executive Vice President and Chief Legal & Compliance Officer
Executive Vice President of Research, Corporate Development, Corporate Strategy & Intuitive Ventures
Executive Vice President, Chief Financial Officer and Head of Business Technology
Compensation
$1,049,570
During the last 12 months, insiders have sold $68.30M worth of ISRG shares, with no buying activity reported.
0
0.00
8.8K
3.88M
-3.9M
-$3.88M
0
0.00
18.9K
9.73M
-9.7M
-$9.73M
0
0.00
60.5K
33.89M
-33.9M
-$33.89M
0
0.00
43.3K
20.81M
-20.8M
-$20.81M
No buying activity
Guthart Gary S
Director
$32.34M
Rosa David J.
Director, Officer: Chief Executive Officer (Ceo)
$13.41M
Curet Myriam
Officer: Evp & Chief Medical Officer
$7.21M
Brosius Mark
Officer: Evp & Chief Mfg And Supply Cha
$6.11M
Charlton Henry L
Officer: Evp & Chief Commercial And Mkt
$2.74M
Strong bearish signal with $68.30M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Heavy recent selling activity. Recent insider sales notably exceed purchasesโmay warrant investigation into company developments.
5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
ISRG - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | March 13, 2026 | December 31, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | March 14, 2025 | December 31, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | March 08, 2024 | December 31, 2023 | 2023 | |
DEF 14A DEF 14A N/A | March 10, 2023 | March 10, 2023 | ย | |
DEF 14A DEF 14A 2022 N/A | March 09, 2022 | April 28, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | August 19, 2021 | August 18, 2021 | 2021 | |
DEF 14A DEF 14A 2021 N/A | March 10, 2021 | March 10, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | March 13, 2020 | April 23, 2020 | 2020 | |
DEF 14A DEF 14A 2018 N/A | March 08, 2019 | December 31, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | March 02, 2018 | December 31, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.